Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

An In Vitro Model of Proliferating CLL Cells for Drug Sensitivity Analysis.

K. Ganeshaguru, PhD, N. I. Folarin, PhD, R. J. Baker, MSc, A. M. Casanova, BSc, A. Bhimjiyani, BSc, A. V. Hoffbrand, DSc, A. B. Mehta, MD, R. G. Wickremasinghe, PhD

Blood (2005) 106 (11): 2956.

https://doi.org/10.1182/blood.V106.11.2956.2956

Published: 2005

Journal Articles

The Role of Multidrug Resistance Proteins and Drug Sensitivity in Relation to Poor Prognosis Identified by ZAP-70 Expression and IgV H Mutation Status in B-CLL.

S. Narat, MD, N. I. Folarin, PhD, R. J. Baker, MSc, V. Duke, PhD, B. C. Yogashangary, BSc, D. T. Jones, PhD, S. M. Hart, PhD, R. G. Wickremasinghe, PhD, A. Victor Hoffbrand, DSc, A. B. Mehta, MD, L. Foroni, MD, K. Ganeshaguru, PhD

Blood (2004) 104 (11): 4791.

https://doi.org/10.1182/blood.V104.11.4791.4791

Published: 2004

Journal Articles

Zap-70 and IgV H Mutation Status in Combination with p53 Functional Analysis Identifies the Response of Poor Prognosis B-CLL Patients to Conventional Cytotoxic Agents.

N. I. Folarin, PhD, R. J. Baker, MSc, V. Duke, PhD, B. C. Yogashangary, BSc, C. Vadikolia, MD, R. G. Wickremasinghe, PhD, A. A. Casanova, BSc, M. W. Lowdell, PhD, A. Victor Hoffbrand, DSc, A. Nathwani, MD, A. E. Virchis, MD, A. B. Mehta, MD, L. Foroni, MD, K. Ganeshaguru, PhD

Blood (2004) 104 (11): 1907.

https://doi.org/10.1182/blood.V104.11.1907.1907

Published: 2004

Journal Articles

Deletion of 13q14.3 and Not 13q12 Is the Most Common Genetic Abnormality Detected in Chronic Lymphocytic Leukemia Cells

P. Panayiotidis, K. Ganeshaguru, A.V. Hoffbrand, C. Rowntree, S.A.B. Jabbar, L. Foroni

Blood (1997) 89 (2): 734–735.

https://doi.org/10.1182/blood.V89.2.734

Published: 1997

Journal Articles

Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia

D Campana, JJ van Dongen, A Mehta, E Coustan-Smith, IL Wolvers-Tettero, K Ganeshaguru, G Janossy

Blood (1991) 77 (7): 1546–1554.

https://doi.org/10.1182/blood.V77.7.1546.1546

Published: 1991

Journal Articles

Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo

AD Ho, K Ganeshaguru, WU Knauf, G Dietz, I Trede, W Hunstein, AV Hoffbrand

Blood (1988) 72 (6): 1884–1890.

https://doi.org/10.1182/blood.V72.6.1884.1884

Published: 1988

Journal Articles

Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance

E Thiel, H Rodt, D Huhn, B Netzel, H Grosse-Wilde, K Ganeshaguru, S Thierfelder

Blood (1980) 56 (5): 759–772.

https://doi.org/10.1182/blood.V56.5.759.759

Published: 1980

NARROW

An In Vitro Model of Proliferating CLL Cells for Drug Sensitivity Analysis.

The Role of Multidrug Resistance Proteins and Drug Sensitivity in Relation to Poor Prognosis Identified by ZAP-70 Expression and IgV H Mutation Status in B-CLL.

Zap-70 and IgV H Mutation Status in Combination with p53 Functional Analysis Identifies the Response of Poor Prognosis B-CLL Patients to Conventional Cytotoxic Agents.

Deletion of 13q14.3 and Not 13q12 Is the Most Common Genetic Abnormality Detected in Chronic Lymphocytic Leukemia Cells

Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia

Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo

Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance

Email alerts

ASH Publications

American Society of Hematology

An In Vitro Model of Proliferating CLL Cells for Drug Sensitivity Analysis.

The Role of Multidrug Resistance Proteins and Drug Sensitivity in Relation to Poor Prognosis Identified by ZAP-70 Expression and IgV H Mutation Status in B-CLL.

Zap-70 and IgV H Mutation Status in Combination with p53 Functional Analysis Identifies the Response of Poor Prognosis B-CLL Patients to Conventional Cytotoxic Agents.

Deletion of 13q14.3 and Not 13q12 Is the Most Common Genetic Abnormality Detected in Chronic Lymphocytic Leukemia Cells

Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia

Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo

Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only